RB family members as predictive and prognostic factors in human cancer - PubMed (original) (raw)

. 2006 Aug 28;25(38):5302-8.

doi: 10.1038/sj.onc.1209620.

Affiliations

• PMID: 16936751
• DOI: 10.1038/sj.onc.1209620

RB family members as predictive and prognostic factors in human cancer

G Scambia et al. Oncogene. 2006.

Abstract

The retinoblastoma family members--pRb, pRb2/p130 and p107--are tumor suppressor genes involved in controlling four major cellular processes: growth arrest, apoptosis, differentiation and angiogenesis. Molecular genetic studies have identified abnormalities of these tumor suppressor genes in a large proportion of human cancers. These genetic alterations have emerged as significant factors in the pathogenesis and progression of many types of tumors and are therefore likely to provide relevant information to assess risk in cancer patients. There is a pressing clinical need to identify prognostic and predictive factors for patients with cancer, because there is an undeniable importance in being able to determine which patients will have a favorable outcome without further therapy (prognostic factor) and which will need some additional treatment (predictive factor). This review examines the predictive and/or prognostic role of each retinoblastoma family member in human cancer.

PubMed Disclaimer

Similar articles

• Involvement of RB gene family in tumor angiogenesis.
  Gabellini C, Del Bufalo D, Zupi G. Gabellini C, et al. Oncogene. 2006 Aug 28;25(38):5326-32. doi: 10.1038/sj.onc.1209631. Oncogene. 2006. PMID: 16936754 Review.
• Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer.
  DiCiommo D, Gallie BL, Bremner R. DiCiommo D, et al. Semin Cancer Biol. 2000 Aug;10(4):255-69. doi: 10.1006/scbi.2000.0326. Semin Cancer Biol. 2000. PMID: 10966849 Review.
• Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation.
  Bellan C, De Falco G, Tosi GM, Lazzi S, Ferrari F, Morbini G, Bartolomei S, Toti P, Mangiavacchi P, Cevenini G, Trimarchi C, Cinti C, Giordano A, Leoncini L, Tosi P, Cottier H. Bellan C, et al. Invest Ophthalmol Vis Sci. 2002 Dec;43(12):3602-8. Invest Ophthalmol Vis Sci. 2002. PMID: 12454024
• Retinoblastoma: from disease to discovery.
  Madhavan J, Ganesh A, Kumaramanickavel G. Madhavan J, et al. Ophthalmic Res. 2008;40(5):221-6. doi: 10.1159/000128578. Epub 2008 Apr 29. Ophthalmic Res. 2008. PMID: 18446017 Review.
• The RB family of cell cycle regulatory factors.
  Stiegler P, Kasten M, Giordano A. Stiegler P, et al. J Cell Biochem Suppl. 1998;30-31:30-6. J Cell Biochem Suppl. 1998. PMID: 9893252 Review.

Cited by

• H19: An Oncogenic Long Non-coding RNA in Colorectal Cancer.
  Chowdhury PR, Salvamani S, Gunasekaran B, Peng HB, Ulaganathan V. Chowdhury PR, et al. Yale J Biol Med. 2023 Dec 29;96(4):495-509. doi: 10.59249/TDBJ7410. eCollection 2023 Dec. Yale J Biol Med. 2023. PMID: 38161577 Free PMC article. Review.
• Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma.
  Liu S, Yang TB, Nan YL, Li AH, Pan DX, Xu Y, Li S, Li T, Zeng XY, Qiu XQ. Liu S, et al. Cancer Med. 2017 Jul;6(7):1512-1522. doi: 10.1002/cam4.1067. Epub 2017 Jun 22. Cancer Med. 2017. PMID: 28639733 Free PMC article.
• The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.
  Labrecque MP, Takhar MK, Nason R, Santacruz S, Tam KJ, Massah S, Haegert A, Bell RH, Altamirano-Dimas M, Collins CC, Lee FJ, Prefontaine GG, Cox ME, Beischlag TV. Labrecque MP, et al. Oncotarget. 2016 Apr 26;7(17):24284-302. doi: 10.18632/oncotarget.8301. Oncotarget. 2016. PMID: 27015368 Free PMC article.
• E2F1: a promising regulator in ovarian carcinoma.
  Zhan L, Zhang Y, Wang W, Song E, Fan Y, Wei B. Zhan L, et al. Tumour Biol. 2016 Mar;37(3):2823-31. doi: 10.1007/s13277-015-4770-7. Epub 2016 Jan 9. Tumour Biol. 2016. PMID: 26749284 Review.
• Promoter Methylation Status Modulate the Expression of Tumor Suppressor (RbL2/p130) Gene in Breast Cancer.
  Ullah F, Khan T, Ali N, Malik FA, Kayani MA, Shah ST, Saeed M. Ullah F, et al. PLoS One. 2015 Aug 13;10(8):e0134687. doi: 10.1371/journal.pone.0134687. eCollection 2015. PLoS One. 2015. PMID: 26271034 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.